Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$182,207
+$82,360 QoQ
Shares Held
13,457
-19.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#243
of 630 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
607,026 | $34,976,838 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $182,207 | 13,457 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $99,847 | 16,669 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $284,419 | 39,668 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $476,103 | 44,579 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $407,450 | 42,092 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $475,556 | 31,938 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $445,406 | 29,853 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $466,083 | 24,364 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $568,380 | 27,458 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $464,153 | 24,689 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $681,792 | 47,281 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $499,724 | 28,786 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $577,456 | 27,749 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $718,536 | 30,550 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $743,329 | 26,614 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $626,839 | 26,788 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $900,045 | 26,668 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $815,720 | 23,353 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $667,494 | 21,921 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $792,698 | 24,175 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $819,561 | 27,084 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||